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Abstract
Heart failure constitutes a major public health problem worldwide. The electrophysiological remodeling of failing hearts sets
the stage for malignant arrhythmias, in which the role of the late Na
+ current (INaL) is relevant and is currently under
investigation. In this study we examined the role of INaL in the electrophysiological phenotype of ventricular myocytes, and
its proarrhythmic effects in the failing heart. A model for cellular heart failure was proposed using a modified version of
Grandi et al. model for human ventricular action potential that incorporates the formulation of INaL. A sensitivity analysis of
the model was performed and simulations of the pathological electrical activity of the cell were conducted. The proposed
model for the human INaL and the electrophysiological remodeling of myocytes from failing hearts accurately reproduce
experimental observations. The sensitivity analysis of the modulation of electrophysiological parameters of myocytes from
failing hearts due to ion channels remodeling, revealed a role for INaL in the prolongation of action potential duration (APD),
triangulation of the shape of the AP, and changes in Ca
2+ transient. A mechanistic investigation of intracellular Na
+
accumulation and APD shortening with increasing frequency of stimulation of failing myocytes revealed a role for the Na
+/
K
+ pump, the Na
+/Ca
2+ exchanger and INaL. The results of the simulations also showed that in failing myocytes, the
enhancement of INaL increased the reverse rate-dependent APD prolongation and the probability of initiating early
afterdepolarizations. The electrophysiological remodeling of failing hearts and especially the enhancement of the INaL
prolong APD and alter Ca
2+ transient facilitating the development of early afterdepolarizations. An enhanced INaL appears to
be an important contributor to the electrophysiological phenotype and to the dysregulation of [Ca
2+]i homeostasis of failing
myocytes.
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Introduction
Over 5 million persons in the United States suffer from heart
failure (HF) and more than 250,000 die annually [1]. Patients with
congestive HF are prone to develop complex ventricular
tachyarrhythmias and some die suddenly [2]. Experimental studies
conducted using animal models of HF have shown that ventricular
arrhythmias are mainly due to non-reentrant mechanisms, most
likely triggered activity based on afterdepolarizations [2].
Much attention has been paid to the understanding of the
arrhythmogenic mechanisms induced by the structural, electrical,
and metabolic remodeling of the failing heart. The electrophys-
iological remodeling of the failing heart has been well described
(see [3,4] for review). Action potential (AP) prolongation, altered
Ca
2+ handling, as well as intracellular Na
+ ([Na
+]i) accumulation
have been established as the hallmark characteristics of myocytes
and tissues isolated from failing human and canine hearts [5–8].
These alterations are closely related to arrhythmogenic mecha-
nisms, such as early (EADs) and delayed (DADs) afterdepolariza-
tions, observed in HF [9]. Functional remodeling of ion channels
and pumps is the underlying cause for AP duration (APD)
prolongation and altered intracellular Ca
2+ ([Ca
2+]i) homeostasis.
Downregulation of outward K
+ currents is the most consistent
change in animal models and human HF [3,4,6,7,10]. Major
changes in intracellular and sarcoplasmic reticulum (SR) Ca
2+
homeostasis are also associated with HF in several animal species,
included human [9,11–13]. In myocytes from failing hearts [Na
+]i
concentration and Ca
2+ handling are closely linked; [Na
+]i is
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animal species [3,4,9,14] and a prominent increase of the human
late Na
+ current (INaL) has also been documented [15,16], and has
been proposed as a therapeutic target [17–19]. Experimental
studies have shown that the INaL is involved in the generation of
EADs in myocytes [17,18] and life-threatening arrhythmias, such
as torsade de pointes (TdP) [20], especially under conditions of
reduced repolarization reserve in several animal species [21–23].
Other changes in biomarkers for arrhythmic risk such as the
increase in the reverse rate-dependent APD prolongation
[20,23,24] have been attributed to an increase in INaL concomitant
with inhibition of outward K
+ currents.
Thus, the goal of our study was to analyze, using computer
simulations, the role of the INaL in the setting of human HF. A
mathematical model of human HF is proposed at cellular level using
a modified version of the Grandi et al. model (from herein referred to
as the GPB model) [25] of endocardial AP, in which a new
formulation of the INaL is included. The sensitivity analysis performed
for the HF model, as well as the simulations of the rate-dependence of
APD and EAD generation revealed that the mechanisms underlying
the arrhythmogenic processes taking place in HF conditions, from a
theoretical point of view, include an enhanced INaL.
Results
Effects of INaL on human AP
Figure 1A shows the generation of INaL trace using a voltage
clamp protocol similar to that of Maltsev et al. [26] in ventricular
mid-myocardial myocytes at room temperature. The simulated
INaL had similar time evolution and amplitude to the
experimental findings. Panels B and C show the effects of this
current on AP and APD at 90% of repolarization (APD90),
respectively. The inclusion of INaL in the GPB model slightly
prolongs steady-state APD at 1 Hz (see Figure 1B). APD remains
within the physiological range for human endocardial myocytes
[8,27,28]. By increasing the magnitude of INaL by a factor of
two-, five- or ten-fold, we obtained APD90 prolongations of 11%,
44% and 78%, respectively. Experimental recordings of
monophasic APs (MAPs) under the effects of veratridine, an
enhancer of INaL, show similar effects on APD prolongation in
rabbit myocytes [29]. We determined the sensitivity of APD90 to
INaL amplitude at different stimulation rates. As shown in
Figure 1C, INaL/INaT ratios, where INaT is the transient peak INa,
were varied from 0.0298% to 1.26% and APD90 significantly
increased according to the magnitude of INaL.F u r t h e r m o r e ,t h e
sensitivity of APD90 increased with the slowing of the stimulation
rate (compare 1 Hz and 0.5 Hz). Similar simulations were
carried out in a rabbit model of AP [30]. As shown in Figure 1D,
the difference in sensitivity of APD90 to changes in frequency of
stimulation (0.5 and 1 Hz) was also observed. Note that the
morphology of the curves in Figure 1D is different to our results,
as different models for INaL and different AP models were used.
The ratio chosen in our model of 0.12% yields an APD90 that is
within the physiological range for 1 Hz indicated by the
discontinuous lines.
Figure 1. Time course of late Na
+ current and its effects on AP. A: Simulation of late Na
+ current (INaL) using a voltage clamp protocol similar
to that of the experimental measurements obtained by Maltsev et al. [26] (shown in the right inset) in ventricular myocytes at room temperature. The
left inset shows an expanded view of the current between 480 ms and 2500 ms. B: Simulated action potentials (APs) at 1-Hz pacing rate using the
GPB model, the GPB model modified with control INaL, and INaL enhanced 2-fold, 5-fold and 10-fold. C: APD90 sensitivity to the INaL amplitude. APs
were simulated at 0.5-Hz (square symbols) and 1-Hz (circle symbols) pacing rate by varying INaL/INaT ratio from 0.0298% to 1.26%. The range of
experimental APD at 90% repolarization (APD90) for human is represented by the two discontinuous lines. D: APD90 sensitivity to the INaL amplitude
(open symbols) taken from Grandi et al. [30] who used a rabbit model.
doi:10.1371/journal.pone.0032659.g001
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APs and [Ca
2+]i transients were simulated under conditions of
HF. Figure 2 shows APs (panel A), [Ca
2+]i transients (panel B) and
Na
+/Ca
2+ exchanger (NCX) function (INCX) (panel C) of failing
(light line) and nonfailing (dark line) ventricular myocytes after
achieving steady-state conditions for a stimulation rate of 1 Hz.
Our results showed an APD90 prolongation of 24% in failing
myocytes versus normal ones, as well as a 18% prolongation in
APD50, so that triangulation (APD90–APD50) increased by 43%
under HF conditions. The experimental observations shown in the
inset of Figure 2 (panel A) taken from reference [5], show the
variability of the APD in failing myocytes from human hearts,
which falls within the simulated values of APD observed.
Figure 2B depicts an altered [Ca
2+]i transient under HF
conditions, as has been documented experimentally and is shown
in the inset [31]. Indeed, diastolic [Ca
2+]i is slightly increased,
whereas peak systolic [Ca
2+]i is reduced to 41% of the one
observed during normal conditions. An additional reported feature
of the [Ca
2+]i transient of a failing myocyte is its slow decay. In our
simulations Ca
2+ transient decay, quantified as the time needed
from the peak value to reach 10% of the transient amplitude (o ˆCa
decay), yielded 630 ms and 380 ms in the failing and nonfailing
myocytes, respectively. Finally, Figure 2C illustrates the changes in
INCX during HF, mainly a shift in the time of the reversal potential
for the NCX (tNCXRP) of 20 ms. Similar shifts in tNCXRP have been
reported in experimental studies [31].
Changes in [Na
+]i and [Ca
2+]i levels under HF conditions at
various stimulation rates were also investigated using a staircase
protocol described in the methods section and described previously
[32–34]. Figure 3A shows that diastolic [Ca
2+]i level is higher in
HF than in normal conditions and systolic level is always higher in
normal conditions than in HF, as reported experimentally
[5,35,36]. The impact of the variability of ion channel remodeling
on these results are presented in Figures S4, S5, S6, S7.
Another feature of myocytes from failing hearts is the high
concentration of [Na
+]i regardless of the stimulation rate, as
observed in Figure 3B and experimentally reported by Pieske et al.
[33] in failing human myocardial cells. However, as acknowledged
by Pieske et al. [33], it should be noted that the absolute [Na
+]i
values in their experimental work were overestimated in normal
and failing hearts. The impact of the variability of ion channel
remodeling on these results are presented in Figures S8 and S9.
To analyze the mechanisms responsible for [Na
+]i accumulation
with frequency in failing myocytes, the above pacing protocol was
applied for a) normal conditions (blue), b) HF conditions (red), c)
HF with no INaL upregulation (purple), d) HF with no Na
+/K
+
pump current (INaK) downregulation (green) and e) HF with no
INCX upregulation (black). From the results obtained in Figure 3B,
it can be deduced that [Na
+]i accumulation is mainly driven in HF
by alterations in INaK, and much less by the INCX and INaL.
Our basic HF model, as described in Figure 2 and 3,
reproduced the main changes in the electrophysiological (EP)
characteristics of myocytes from failing hearts. However, the
experimentally reported ranges for EP changes, as well as the
magnitude of ion channels, transporters and respective current
remodeling, vary substantially for different experimental settings
and HF stages. Hence, we performed a sensitivity analysis to assess
the impact of the main ionic parameters remodeled in HF on the
described EP characteristics. Figure 4A highlights the role of INaL
and INaK in APD90 under conditions of HF. When INaL undergoes
a 2-fold increase (i.e. doubling) with respect to the basic HF
increase, APD is prolonged 22% and no change at all in this
current leads to a shortening of the APD90 by 10% with respect to
basic HF conditions. This result is in agreement with experimental
recordings in failing human myocytes, where INaL has a crucial
role in APD [19]. Similarly, the downregulation of Na
+/K
+ pump
in HF has a relevant effect on APD90 shortening, and further
reduction of the current leads to a decrease of 22% with respect to
HF APD90 value, which is in agreement with experimental
observations [37]. Figure 4B reveals the importance of INaK,I NCX,
the background Ca
2+ current (ICab), the leak Ca
2+ current (Ileak),
and INaL in determining the value of peak systolic [Ca
2+]i during
HF. Regarding the regulation of [Na
+]i value in failing myocytes,
Figure 4C shows the important role of INaK,I Cab, the inward
rectifier K
+ current (IK1), INCX and INaL. To summarize the
sensitivity of some of the EP characteristics (1
st column) during HF
to the altered ionic parameters (1
st row), Figure 5 shows the
relative sensitivity normalized to the maximum sensitivity for that
particular characteristic, as described in the methods section. The
positive and negative signs indicate whether the change of the
ionic current and the HF EP characteristic follow the same or
inverse tendency, respectively. Percentages in each box indicate
the maximum absolute sensitivity of the EP parameter correspon-
dent to that row for all ionic properties. From this sensitivity
analysis it could be deduced that APD was particularly sensitive to
INaL and to INaK (green and burgundy colors in rows 1 and 2).
Furthermore, IK1,I NCX and INaK have an important effect on AP
triangulation. The main features of Ca
2+ transient in HF (3
medium rows) were mainly influenced in this order by INaK,
SERCA function, INCX,I leak,I Cab, and INaL. The SR Ca
2+
concentration ([Ca
2+]SR) is also influenced by other currents but in
this case Ileak becomes more important than INCX. [Na
+]i is mainly
regulated by INaK,I Cab,I K1,I NCX and INaL. Finally, tNCXRP is
mainly modulated by the SR Ca
2+-ATPase activity (ISERCA). The
absolute effects of small changes (615%) in the ionic remodeling
of the basic HF model on the main results of our simulations are
Figure 2. Electrophysiological changes in heart failure. Simulated APs (panel A), [Ca
2+]i transients (panel B), and Na
+/Ca
2+ exchanger (NCX)
activity (panel C) at 1-Hz pacing rate in control (dark line) and in heart failure (HF) conditions (light line). The insets show experimental recordings of
Priebe and Beuckelmann et al. [5] (panel A) and Weber et al. [31] (panel B).
doi:10.1371/journal.pone.0032659.g002
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These absolute effects are in agreement with the relative role of the
ionic parameters described above. We have especially focused on
the sensitivity of APD90 in failing myocytes to INaL/INaT ratio, as
shown in Figure S1. In this figure, the values of INaL/INaT ratios
for 1 Hz in the modified the GPB model and in our basic HF
model are indicated by arrows and are within experimental ranges
(indicated by blue dotted lines in normal myocytes and by red
discontinuous lines in failing myocytes, respectively). Changes in
the selected ratios affect the APD90 values of failing and normal
myocytes, which stay within experimental ranges provided that the
changes of these ratios are not very large.
APD rate-dependence and the role of INaL in HF
The role of INaL in steady-state APD90 rate-dependence during
HF was analyzed. An enhanced reverse frequency-dependence of
APD90 is considered to be a major proarrhythmic risk (see [38] for
review). We performed simulations and measured APD90 under
normal and HF conditions for different magnitudes of INaL
activation (see Figure 6A). Also 40% and 60% inhibition of the
rapid component of the delayed rectifier K
+ current (IKr) in failing
myocytes were simulated with different degrees of INaL enhance-
ment (see Figure 6B). Indeed, the concomitant alteration of INaL
and IKr has been reported to have important effects on
arrhythmogenicity [20–24]. An important result obtained in our
simulations, as shown in Figure 6A, is the reverse rate-dependence
effect on APD90 exerted by INaL enhancement for normal
conditions (compare circles with stars). The rate-dependence
yielded 110 and 190 ms maximal APD90 prolongation in normal
conditions versus INaL increased by 4-fold, respectively. Similar
observations were reported by others [20,24] in rabbit ventricular
myocytes under the effects of INaL activators, as well as in isolated
perfused rabbit heart [22]. When considering HF conditions
(squares), the rate-dependence is also increased with respect to
normal conditions. The DAPD value is very similar to the value
obtained with INaL enhanced (stars). This implies that INaL might
be the main driver of the increased reverse rate-dependent
prolongation of APD. Additionally, greater magnitudes of INaL
(black triangles) are associated with greater increase in the reverse
rate-dependency of APD of failing myocytes. Experimental studies
[7] have also documented the increase of APD rate-dependence in
human failing epicardial myocytes, as depicted in the inset.
Simulations of APD rate-dependence in HF caused by small
changes (615%) in the ionic remodeling of the basic HF model
(see Figures S2, S3, S4, S5, S6, S7, S8, S9, S10, and S11) to take
into account the experimental variability on electrical remodeling
during HF were also performed. The results do not change
significantly with respect to the basic HF model, except for INaK
and INaL, which have an important effect on APD90, as predicted
by the sensitivity analysis shown in Figure 5.
Figure 3. [Ca
2+]i and [Na
+]i changes with increasing frequency in HF. Influence of the stimulation rate on [Ca
+2]i (panel A) and [Na
+]i in nmol/L
(panel B) determined using the staircase protocol. The simulations were performed using the modified GPB model with INaL incorporated in normal
conditions (blue) and the modified GPB model incorporating HF conditions (red). In panel B, conditions of HF without INaL,I NaK or INCX remodeling are
also shown.
doi:10.1371/journal.pone.0032659.g003
Figure 4. Sensitivity of electrophysiological parameters to changes in ionic current properties. Changes in APD90 (panel A), peak systolic
[Ca
2+]i (panel B), and [Na
+]i (panel C) with changes in INaL,I NaK,I leak,I NCX,I K1 and ICab, as labeled next to each curve. Axis x represents the simulation
conditions; for ‘‘HF Conditions’’ the remodeling of the basic HF model is considered, for ‘‘No Change’’ the labeled current is unchanged as it is in the
GPB model, for ‘‘Double Change’’ the labeled current undergoes a double change with respect to the change exerted in ‘‘HF conditions.’’
doi:10.1371/journal.pone.0032659.g004
Simulation Study of Heart Failure
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enhancement and IKr inhibition in the reverse rate-dependency of
APD, shown in various experimental studies [20,24], in failing
myocytes.
To analyze the ionic mechanisms responsible for steady-state
APD rate-dependence in failing myocytes, we determined the
behavior of several ionic currents (INaL,I NCX and INaK) and [Na
+]i
at different frequencies of stimulation, as depicted in Figure 7. Our
results show that the shortening of the APD with increased
frequency in HF is explained on the one hand by the decrease in
INaL, indeed faster rates lead to an incomplete recovery from
inactivation of this current [39–41], and on the other hand by
[Na
+]i accumulation leading to an increase of INaK. The role of
INCX on APD is not evident as both outward and inward modes
are enhanced. Although several experimental studies suggest the
direct involvement of this current on APD shortening with
Figure 5. Relative sensitivities of the electrophysiological parameters to changes in ionic current properties. Dark blue color indicates
lack of dependency between the ionic property (1
st row) and the EP parameter (1
st column), and dark red color indicates strong direct (+)
dependency or inverse dependency (2). Percents in each box indicate the maximum absolute sensitivity of the EP parameter correspondent to that
row for all ionic properties.
doi:10.1371/journal.pone.0032659.g005
Figure 6. Role of INaL in APD rate-dependence in HF and reduced repolarization reserve. Simulated APD dependence on stimulation
frequency for normal (circles in panel A) and HF (squares in panel A) conditions and in the presence of enhanced INaL in normal (stars in panel A) and
HF (triangles in panel A) conditions. The inset shows experimental results of Li et al. [7]. Panel B, depicts the APD rate-dependence for HF combined
with different degrees of IKr inhibition and INaL enhancement.
doi:10.1371/journal.pone.0032659.g006
Simulation Study of Heart Failure
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simulations is not evidenced. Indeed, when we stimulated the cell
at high frequency (1.6 Hz) but clamped [Na
+]i value to the lower
[Na
+]i value corresponding to the low frequency (0.5 Hz), we
observed a decrease in APD90 with respect to APD90 at low
frequency, concomitant with a decrease and increase of the
outward and inward modes of NCX activity, respectively (results
not shown). These changes in INCX should lead to a longer APD90,
instead of shorter, suggesting that INCX is not determinant in APD
rate-dependence in the present model.
Arrhythmogenic effects of INaL
Under basic HF conditions, APD prolongation favors the
occurrence of EADs. We were therefore interested in determining
the role of INaL in the repolarization abnormalities of human failing
hearts. We stimulated the myocyte at 1 Hz and simulated
conditions of low repolarization reserve prone to EADs generation.
Under HF conditions using the basic HF model, IKr was reduced by
50% and the Ca
2+ current (ICaL) was increased by 30%. Figure 8A
shows EADs (dark line) when INaL was doubled, whereas APs
displayedno EADs when INaL was normal (light line). The impact of
the variability in ion channel remodeling on EADs generation can
be observed in Figures S10 and S11. The mechanisms by which
EADs arise are dictated by a very delicate balance of ionic currents
during AP plateau. Slight changes in this balance can suppress
EADs, as occurs in the case when all ionic parameters are reduced
in 15% with respect to the basic HF model (see Figure S11).
Figure 8 depicts APs and ionic currents to provide insight into
the mechanisms by which enhancement of INaL indirectly triggers
EADs [17]. The APD prolongation (panel A) caused by
enhancement of INaL (panel B) leads to the reactivation of the
activation gate d (panel F) of the ICaL, which triggers the EAD, as
was suggested by January et al. [42]. However, the important
contribution of the altered Ca
2+ transient should also be taken into
Figure 7. Mechanisms for APD rate-dependence in HF. Simulated APs and ionic currents at different stimulating frequencies (0.5, 1, 1.25 and
1.6 Hz) under HF conditions.
doi:10.1371/journal.pone.0032659.g007
Figure 8. Mechanisms for early afterdepolarizations with enhanced INaL. Simulated APs and ionic currents at a stimulating rate of 1 Hz for
HF conditions, 50% inhibition of IKr and 30% increase of ICaL. Panel A shows early afterdepolarizations (EADs; dark line) when INaL was doubled and
APs with no EADs when INaL was normal (light line). The temporal evolutions of INaL (panel B), Irel (panel D), ICaL (panel C), NCX activity (panel E), and
activation gate of ICaL are also depicted when INaL was doubled (dark line) and when INaL was normal (light line).
doi:10.1371/journal.pone.0032659.g008
Simulation Study of Heart Failure
PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e32659consideration. Indeed, the APD prolongation caused by INaL
enhancement alters Ca
2+ handling. As observed in panel C,
[Ca
2+]SR remains elevated and provokes the trigger of a small
spontaneous release (panel D, arrow) just before the EAD arises
(panel A, arrow). NCX (panel E) extrudes Ca
2+ operating in the
inward mode, which contributes to membrane potential increase.
This would contribute to ICaL reactivation which triggers the
EAD. The involvement of these currents is also shown in Figures
S12, S13, S14, and S15, as a partial block of SR Ca
2+ release (Irel)
or INCX suppresses the EADs.
Discussion
Major Findings
In this article, one of the most recent and detailed AP model for
human ventricular myocytes, the GPB model, was modified to
simulate HF functional remodeling. The INaL was formulated and
introduced in the model on the basis of human ventricular voltage-
clamp data. An important novelty of the study is the sensitivity
analysis of the modulation of the main EP characteristics due to
ion channel and transporters remodeling, highlighting the role of
INaL in the changes of APD, triangulation and Ca
2+ transient
under HF conditions. A mechanistic investigation of [Na
+]i
accumulation and APD shortening with increasing stimulation
frequency in failing myocytes, revealed the roles of INaK,I NCX and
INaL. Finally, the arrhythmogenic effects of increased INaL were
investigated. Our results showed the important role of INaL in APD
reverse rate-dependence and EAD generation in failing myocytes,
representing the first realistic simulation study on this issue, which
complements experimental studies and sheds light into the ionic
mechanisms responsible for HF phenotype.
Simulation of heart failure
Recently, O’Hara et al. [43] published a new AP model for
human ventricular myocytes; however, in the present study the
GPB model was chosen because its behavior was adequate to
analyze the changes exerted in HF in APD, Ca
2+ transient, the
APD rate-dependence and EADs generation. Nevertheless future
studies comparing the behavior of both models in pathological
situations should be conducted. The GPB model was developed
using human voltage-clamp data, and validated against recent
experimental results [25]. In the present study, we demonstrate for
the first time that the GPB model, subject to ion channel and
transporter remodeling, is also appropriate to reproduce the
electrical behavior of failing myocytes.
A large body of experimental research has focused on the
functional remodeling of failing hearts [3,4,6,7,10,11,14]. How-
ever, little has been done in this field from a theoretical
perspective. One of the first human ventricular AP models,
including HF remodeling, was formulated by Priebe and
Beuckelmann in 1998 [5]. However, INaL was not considered,
and the formulation of Ca
2+ handling was not as realistic as it is
in the GPB model. This represents an important limitation for
HF, when Ca
2+ transient undergoes critical changes. Later, in
2005, Zhang et al. [44] modified the human ten Tusscher model
[45] to simulate HF. In the latter model, INaL was considered, but
with experimental data derived using dog ventricular myocytes
[46], and remodeling was derived using experimental data from
multiple species. However, controversy about the changes
introduced in their model for INaT, the slow component of the
delayed rectifier K
+ current (IKs)o rI CaL exists for human failing
myocytes [2–4]. Other authors have simulated ion remodeling of
myocytes from canine and rabbit failing hearts [12,47] that
reproduce the APD and Ca
2+ transient changes associated with
HF. Our model of basic HF not only reproduces experimental
observations on APD prolongation and Ca
2+ transients alter-
ations [5,7,11,31], but also the APD, [Ca
2+]i and [Na
+]i rate-
dependence reported in failing myocytes [33,35,36]. The ionic
model of ventricular HF presented in this study is not only based
on recent human experimental data, but also takes into account
the variability documented in EP studies using sensitivity analysis.
Sensitivity analysis also elucidates the ionic mechanisms respon-
sible for the main changes in the EP characteristics of HF.
Previous sensitivity analysis have been performed using the
human ten Tusscher et al. [48] AP model [32], a modified
version of the GPB model [34] and O’Hara et al. model [43], as
well as rabbit [48] AP model. In these studies, the authors
analyzed the effects of the physiological variability of the main
ionic properties on several electrophysiological characteristics and
biomarkers for arrhythmic risk, under normal physiological
conditions. The main similarities of our results in HF with their
studies on normal myocytes, are the importance of INaK [32,34]
and INaL [43] in regulating APD90,a n dI K1 [32,34] and INaK in
regulating AP triangulation. The variability of ICaL and IKr has
also an important effect in their studies but was not considered in
HF, as these currents are not remodeled. Also the impact of INaK
and INCX was important on Ca
2+ transients under normal
conditions [32,34].
Regarding the variability of functional remodeling in HF, it is
worth noting that experimental measurements reported in
literature have been conducted in different stages of HF (see
[3,4] for review). In the present study, ionic currents are within
experimental ranges, but do not take into account differences in
various stages of HF. Different combinations of changes were
tested in the sensitivity analysis in order to determine the relative
effects on the EP characteristics in HF (Figure 5) and the absolute
effects of small changes (615%) in ionic parameters on APD-rate-
dependence (Figures S2 and S3), [Ca
2+]i transients (Figures S4, S5,
S6, and S7), [Na
+]i values (Figures S8 and S9) and EADs
generation (Figures S10 and S11). It should be noted that the
results of the present sensitivity analysis are dependent on the
values chosen for the ionic parameters in the basic HF model, as
the percents of change also depend on these chosen values. The
results suggest that the downregulation of the Na
+/K
+ pump has
an important role in the electrophysiological and Ca
2+ transient
changes in HF, highlighting the need for new experimental data.
Electrophysiological studies [49] conducted in failing human
hearts revealed increased Ca
2+ transients under the effects of
strophanthidin, a Na
+/K
+ pump blocker, which is in agreement
with our results. However, little is known about the effects of Na
+/
K
+ pump activity on APD in HF. Experiments carried out on
hypertrophic rat hearts by Levi et al. [37] showed that the
application of ouabain, a Na
+/K
+ pump blocker, resulted in APD
shortening, which was caused by [Na
+]i accumulation and the
subsequent increase in the reverse mode of the NCX. Similar
studies should be performed using human failing hearts to
determine the role of the effects of Na
+/K
+ pump on APD. Also
the [Na
+]i accumulation with increasing frequency during HF
appears to be mainly due to the downregulation of this pump, and
a small contribution of INaL and INCX upregulation (see Figure 3B).
Experimental studies reporting [Na
+]i accumulation in human HF
[33] or animal species [35,50] suggest that INaK downregulation,
INaL and INCX upregulation, and altered activity of the Na
+/H
+
exchanger (not included in the GPB model), might be involved.
However, no experiments have been performed to in human
failing myocytes to clarify the responsible mechanisms. Other
simulation studies [30,51] using the Shannon et al. rabbit AP
model [52] have also reported the small and important influence
Simulation Study of Heart Failure
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+]i accumulation with
frequency under pathological situations other than HF.
Our results also reveal the role of INaK in APD rate-dependence
as stated by Carmeliet [53] and by Eisner et al. [54] in their review
on AP rate adaptation as well as shown in the theoretical and
experimental findings by Pueyo et al. [55]. Additional simulation
studies using different human AP models have also demonstrated
this fact in normal conditions [32,43]. Although O’Hara et al. [43]
and Carro et al. [34] human AP models exhibit an improved
behavior in the fast phase of APD rate adaptation than the GBP
model, our study focused on the steady-state APD rate-
dependence, where the GPB model is valid except for low
frequencies [43]. Also Faber and Rudy [56] showed that APD
shortening at high rates in a guinea pig AP model was due to the
increase of the outward NCX activity. This observation is also
consistent with experiments conducted on myocytes from human
failing hearts [49], where increases in [Na
+]i led to APD
shortening provoked by an increase of the reverse mode of INCX.
However, the GPB model exhibits a much shorter outward mode
of NCX than the Faber and Rudy model. Thus its contribution to
AP repolarization is not evident in the present study. Furthermore,
in failing human myocytes, Ca
2+ influx via NCX is prominent
during most of the plateau phase [31]. Thus changes in INCX
formulation of the GPB model should be addressed to better
understand the role of this current in HF APD rate-dependence.
Also new experiments in failing human myocytes demonstrating
the role of INaK and INCX in APD rate-dependence would be of
great interest. This finding also suggests that the functional
increase of these outward currents caused by [Na
+]i accumulation
may limit AP prolongation in HF, counterbalancing the increase
of INaL.
Our results also highlight the pivotal role of INaL in the changes
of EP characteristics in HF, which will be discussed in the
following section. Finally, another mechanistic effect of relative
importance in HF, revealed by the simulations of the present study
is the increase of AP triangulation associated with IK1 downreg-
ulation. Similar observations have been reported in ventricular
myocytes from normal dogs when IK1 was reduced with barium
[57] and in the sensitivity analysis performed by Romero et al.
[32] and Carro et al. [34] in normal physiological conditions.
Important role of INaL during heart failure and clinical
implications
The pivotal role of INaL in the changes of EP characteristics and
in arrhythmogenesis in HF has been uncovered in the present
work. The formulation of the INaL model and its introduction in
the GPB model was essential to draw our conclusions. Previous
formulations have been proposed to model the behavior of INaL for
different animal species using the Hodgkin-Huxley or Markov
formalisms [19,20,30,46,58,59]. Noble and colleagues [59] in
1998 formulated the INaL for guinea pig by adding to their AP
model a Na
+ current with reduced conductance and slow
inactivation. Similarly, other Hodgkin-Huxley formulations have
been proposed for rabbit [20] and dog [19,46]. To avoid the
complexity of Markov models for INaL [30], we adapted the
Hodgkin-Huxley mathematical description of Hund et al. [46] to
human data, as we did in a previous work using ten Tusscher et al.
AP model [48]. Our model has been validated against experi-
mental recordings of human APD in normal conditions [8,27,28],
APD prolongation under the effect of drugs [29] and voltage
clamp experiments [58]. Recently, a new AP model for human
ventricular myocytes has been published by O’Hara et al. [43]
including a formulation for INaL as in the present work. However,
as their AP model includes CaMK regulation, their formulation of
INaL also includes the effect of CaMK regulation.
In agreement with previous experimental observations, the
upregulation of INaL during HF [15] or its enhancement in
situations of reduced repolarization reserve [21] prolongs APD,
causes AP triangulation and increase the reverse rate-dependent
prolongation of APD, which are important harbingers for cardiac
arrhythmias. The contribution of INaL in the reverse APD rate-
dependence was also previously simulated by our group [60] using
a different human AP model [48] and conditions of reduced
repolarization reserve. In regard to HF conditions, there is
background of decreased outward currents, and even a small
increase of INaL becomes more efficient in prolonging APD and
favoring the trigger of EADs. The high probability of formation of
EAD, leading to TdP, during HF has been experimentally
demonstrated [7] but few studies have addressed the role of INaL
in such situations [18,26,61]. Our results are in keeping with
experimental findings, in which the INaL blocker ranolazine,
effectively suppresses EADs from ventricular myocytes from failing
hearts [18,23]. Furthermore, during conditions of reduced
repolarization reserve, in which outward K
+ currents are inhibited
by drugs or by diseases, results of experimental studies [21–23,62]
have unmasked the role of endogenous or enhanced INaL in
exerting proarrhythmic effects. This is in agreement with the
results of our simulations, and provides evidence of this effect in
HF. Our findings support the hypothesis that INaL represents an
important target for triggered-arrhythmias treatment [13]. Simi-
larly, inhibition of CaMKII, which is known to be responsible for
ICaL and ryanodine receptor phosphorylation as well as INaL
regulation, appears to be an important therapeutic target for
suppressing arrhythmias in HF [13,17,63].
Limitations of the study
Several limitations need to be considered, when drawing
conclusions from the present study. The model for INaL was
formulated on the basis of voltage-clamp human data for mid-
myocardial cells [58], as no measurements were available for
endocardial or epicardial cells. Indeed, INaL is difficult to record
due to the very low magnitude (,30–60 pA) of this current under
normal conditions [58]. Maltsev and Undrovinas reported a
double exponential decay of INaL [58]. However, we chose a
single-exponential decay formulation as proposed in previous
studies [46,64], and also in the new AP model by O’Hara et al.
[43], as this model was able to reproduce its main effects on the
AP. To build the model of HF used in the present study, the ionic
remodeling was mainly based on experimental data observed in
human hearts. Data from a large number of experimental studies
have been taken into account, thus resulting in a high variability
not only in the ionic remodeling but also in the stage of HF. In
addition to the difficulties associated with gaining access to human
hearts, explanted diseased hearts are usually in the end stage of
HF. Moreover, there are controversies regarding specific ion
channel currents remodeling during HF, such as INaT,I CaL IKr,
and IKs, and changes in these currents were not included in our
HF model. Their effects on the EP characteristics would be
significant contributors to the phenotype. We did however
simulate changes in INaL concomitant with inhibition of IKr and
increase in ICaL (Figures 6 and 8). Finally, our basic HF model has
the inherited limitations described for the GPB model. In this
sense, improvements related to the rapid phase of APD rate
adaptation have been accomplished in later human AP models
[34,43]. The response of failing myocytes to abrupt changes of the
stimulation rate was however out of the scope of the present study
because of the lack of availability of experimental data in HF. With
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accurate except for very low frequencies [43]. Thus the results
obtained for APD90 at low frequencies should be taken with
caution.
Conclusion
This study aimed to investigate in silico the role of INaL in the
electrophysiological and Ca
2+ homeostasis phenotype of myocytes
from failing hearts. Our results showed that the enhancement of
this current during HF can lead to important prolongation of APD
and triangulation, increases in reverse rate-dependent prolonga-
tion of APD, significantly contributes to Ca
2+ handling changes
and has an indirect but pivotal role in the genesis of EADs.
Methods
Model of the human ventricular INaL
To simulate the electrical activity of human ventricular
myocytes, the AP model formulated by Grandi et al. [25] for
endocardial cells was used. This model is one of the latest and most
detailed mathematical model for ionic currents and Ca
2+ handling
of the human ventricular AP. A particular strength of the GPB
model is its ability to reproduce the rate-dependence of APD upon
outward K
+ currents block and their individual role in
repolarization. Thus, this model provides a powerful tool to
explore repolarization abnormalities under conditions of disease,
such as HF. However, in order to realistically simulate HF, an
important issue remains unresolved in this model, namely the role
of INaL.
We included in the GPB model a new formulation for human
INaL that is described in equations (1) to (4) and is based on the
formulation we included previously [60] in the AP model
formulated by ten Tusscher et al. [48].
INaL~gNaL:mL













We adopted these equations following Hodgkin Huxley formalism,
where the activation gate (mL) and the Nernst potential for Na
+
(ENaL) were unchanged with respect to INaT formulation in the
GPB model. The steady-state inactivation gate (hL‘) was taken
from Maltsev et al. [64], as did Hund et al. in their model for
canine ventricular myocytes [46]. The maximum conductance
(gNaL) and the time constant of inactivation (thL) were fitted to
reproduce INaL data taken from human mid-myocardial myocytes
[58]. In their experiments, Maltsev et al. [58] measured an INaL/
INaT ratio of approximately 0.1% using a voltage clamp protocol at
room temperature. In our model gNaL was fitted accordingly using
voltage clamp simulations, yielding 0.015 mS/mF. No correction
factor for temperature was applied, as we assumed that INaL/INaT
ratio does not change with temperature in myocytes, as reported in
transfected HEK-293 cells [65]. However, because experimental
data indicate that ion channel dynamics are altered by
temperature, the time constant of inactivation (thL)o fI NaL
reported by Maltsev et al. [26] for human ventricular mid-
myocardial myocytes was multiplied by a Q10 factor of 2.2 [65],
yielding 233 ms at 37uC.
Heart failure cellular model for human
The remodeling of myocyte electrophysiology in HF is well
described [3] and can explain for the most, the hallmark
characteristics of failing cardiac tissues and myocytes, such as AP
prolongation and alteration of Ca
2+ and Na
+ handling [2,6,66]. On
the basis of experimental observations [3,4,7,9,11,13–15,67] and
previous simulation studies [5,12,44,47], we hereby propose various
changes in the formulation of several ionic currents of the GPB
model to reproduce the reported experimental changes in AP and
intracellular Ca
2+ and Na
+ handling in ventricular myocytes from
failing human hearts [8,31,66]. Our model will be referred to as the
basic HF model. Table 1 summarizes the changes we made in the
different ionic properties with respect to the GPB model. The ionic
remodeling is mainly based on experimental data observed in
human hearts.
A prominent increase in INaL and slowing of current decay has
been described in ventricular mid-myocardial myocytes isolated
from failing hearts of dogs and humans [15,67]. Accordingly, the
current density and the time constant of inactivation were
increased two-fold compared to non-failing cells. Although
Maltsev et al. [15] reported a smaller increase in both values in
failing myocytes, their experiments were performed at room
temperature and stated that the changes are expected to increase
at physiological temperature. Furthermore, the values of the time
constant of inactivation could be measured for human myocytes,
but the current density was only given for dog myocytes, as the
authors state the difficulty to measure it in human myocytes where
the variability was very high. Also, in a previous study by Valdivia
et al. [16], INaL was increased 5-fold in human failing myocytes
with respect to normal myocytes. Downregulation of K
+ currents
is the most consistent ionic current change observed in myocytes
isolated from failing hearts from animal models and humans
[6,7,10]. Mainly, Ito is downregulated without a significant change
in the voltage dependence or kinetics [10]. We reduced the
transient outward K
+ current (Ito) to 40% of its normal value.
Reported changes in IK1 functional expression are more variable
than Ito [3,10] and have a strong dependence on the etiology. The
conductance of this ion channel was multiplied by 0.68 as in [12],
a value within the experimental range. In regards to [Na
+]i
handling, which is also altered in HF, we reduced INaK activity by
10%, as the preponderance of experimental data reveal that the
expression and function of the Na
+/K
+-ATPase are reduced in HF
[3,4,14]. Similar to that of Priebe and Beuckelmann simulation
study [5], the background Na
2+ current (INab) was not included in
our HF model. Finally, the changes in intracellular and SR Ca
2+
homeostasis were achieved by an increase of 75% of INCX
[5,12,68], and a decrease of 50% of ISERCA [11]. To reproduce the
experimentally observed changes in Ca
2+ sensitivity of the
ryanodine receptor (RyR) [13,69], Ileak was increased 3-fold and
the parameter EC50SR for SR [Ca
2+]-dependent activation of SR
release (see Grandi [25] supplementary data) was reduced to
0.4 mM. The background Ca
2+ current was changed as in the
study of Priebe and Beuckelmann [5].
Sensitivity analysis of the HF model
A sensitivity analysis was performed to investigate how the
reported variability in HF remodeling data might modulate the
main EP characteristics in HF. These characteristics ‘‘c’’ include
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triangulation, peak systolic and diastolic [Ca
2+]i transient, o ˆCa
decay, peak systolic and diastolic [Ca
2+]SR, [Na
+]i, and tNCXRP.
These characteristics were calculated at steady-state HF conditions
(HF basic model) and after varying one parameter ‘‘p’’ at a time.
The parameters included each of the ionic current properties
modified in the HF basic model, and were varied to its normal
value, as in the GPB model, and to a value representing twice that
observed in the HF basic remodeling. Although an important
change has been implemented (double change) to be considered as
a high variability, only the sensitivity, i.e. the relative effect was
analyzed. The sensitivity analysis performed similar to that of
Romero et al. [32], wherein the indexes percentage of change









with Cp,x and CHFbasic being the magnitude of the characteristic c
when parameter p undergoes a double change (x=2) with respect
to the HF basic change, or no change at all (x=1); Da is the total
interval of change of parameter p.
Stimulation protocols
Voltage clamp was used to simulate INaL behavior. A voltage
pulse to 220 mV was applied from a holding potential of
2120 mV as depicted in the inset of Figure 1A. To calculate INaL/
INaT ratios (see Figure 1C) INaL was measured at 40 ms after the
application of the depolarizing pulse and was divided by peak INaT.
Cellular simulations wereconducted at a stimulation rate of1 Hz.
Measurements were taken after achieving steady-state conditions.
Table 1. Heart failure remodeling.
% Change vs. GPB References Experimental conditions
INaL q 200 Maltsev et al., 2007 [15] Isolated cardiomyocytes from LV mid-myocardium of failing dog hearts. Whole cell
voltage clamp (room temperature)
Valdivia et al., 2005 [16] Isolated cardiomyocytes from LV of failing human hearts. Whole cell voltage clamp
(room temperature)
o ˆ hL q 200 Maltsev et al., 2007 [15] Isolated cardiomyocytes from LV mid-myocardium of failing human hearts. Whole cell
voltage clamp (room temperature)
Ito Q 60 Wettwer et al., 1994 [70] Isolated cardiomyocytes from LV endocardium of failing human hearts. Whole cell
voltage clamp (room temperature)
Beuckelmann et al., 1993 [10] Isolated cardiomyocytes from LV mid-myocardium of failing human hearts. Whole cell
voltage clamp (room temperature)
Nabauer et al., 1996 [71] Isolated cardiomyocytes from LV endocardium of failing human hearts. Whole cell
voltage clamp (room temperature)
IK1 Q 32 Tomaselli et al., 1999 [3] Review article. Several species.
Beuckelmann et al., 1993 [10] Isolated cardiomyocytes from LV mid-myocardium of failing human hearts. Whole cell
voltage clamp (35uC)
Li et al., 2004 [7] Isolated cardiomyocytes from RV epicardium of failing human hearts. Whole cell
voltage clamp (room temperature)
INaK Q 10 Bundgaard et al., 1996 [14] Measurements of human myocardial. Na,K-ATPase concentration in failing hearts
Tomaselli et al., 1999 [3] Review article.
Tomaselli et al. 2004 [4] Review article.
INab =0 Priebe and Beuckelmann, 1998 [5] Simulation of human HF.
ICab q 153 Priebe and Beuckelmann, 1998 [5] Simulation of human HF.
NCX q 175 Priebe and Beuckelmann, 1998 [5] Simulation of human HF.
Reinecke et al. 1996 [68] The functional activity of the Na
+-Ca
2+ exchanger was determined by measuring the
Na
+-dependent Ca
2+ uptake into membrane vesicles prepared from human left
ventricular samples
SERCA Q 50 Piacentino et al., 2003 [11] Isolated cardiomyocytes from LV of failing human hearts. Measurements of Ca
2+ uptake
rates by the SR (37uC).
Hasenfuss et al., 1994 [72] Endocardial strip preparations from human failing hearts. Measurements of Ca
2+
uptake in myocardial homogenates (37uC).
Schwinger et al., 1995 [73] LV from human failing hearts. Measurements of Ca
2+ uptake.
Ileak q 500 Bers et al., 2006 [9] Review article.
EC50SR Q 11 Curran et al., 2010 [69] Isolated cardiomyocytes from LV of failing rabbit hearts. Measurements of RyR
sensitivity to SR Ca
2+.
Antoons et al., 2007 [13] Review article.
Bers et al., 2006 [9] Review article.
Changes in ion channel, transporters, and pumps activities, and constants used in the basic heart failure (HF) model. The changes are indicated in percentage of increase
(q) or decrease (Q) with respect to the Grandi et al. model (the GPB model) [25].
doi:10.1371/journal.pone.0032659.t001
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+]i and [Ca
2+]i levels at various stimulation rates
were measured using a staircase protocol as previously described
[32,33]. Cardiomyocytes were stimulated at increasing fast
frequencies (0.5, 1, 1.5, 2 and 2.5 Hz) for 10 minutes, and
[Ca
2+]i and [Na
+]i levels were recorded for each of the frequencies.
To analyze the APD rate-dependence, simulations were
performed at different frequencies of stimulation (0.5, 1, 1.25
and 1.6 Hz). Measurements of APD90 were taken after achieving
the steady-state; likewise for APs, [Na
+]i and several ionic currents.
The rate-dependence was measured as the difference between the
maximum APD90 for a stimulation rate of 0.5 Hz and the
minimum APD90 corresponding to the highest stimulation
frequency.
Supporting Information
Figure S1 Sensitivity of APD90 to the INaL amplitude in
HF. Steady-state APs at 1 Hz (square symbols and solid lines) and
0.5 Hz (circle symbols and dashed lines) pacing rates with varying
INaL/INaT for normal conditions using the GPB model (thick lines)
and under basic HF conditions (thin lines) where INaL is doubled
with respect to normal conditions. The range of experimental
APD90 for human for normal conditions is represented by the two
dotted blue lines. The range of experimental APD90 for human for
HF conditions is represented by the two discontinuous red lines.
(TIF)
Figure S2 Sensitivity of APD rate-dependence to varia-
tions in individual ionic parameters in HF. The steady-
state APD90 for different stimulation frequencies is shown for
normal conditions using the GPB model (thick line), for basic HF
conditions (solid line), and for a 15% increase (long dashed line)
and a 15% reduction (short dashed line) of one ionic parameter
with respect to its value in the basic HF model.
(TIF)
Figure S3 Sensitivity of APD rate-dependence to varia-
tions in all ionic parameters in HF. The steady-state APD90
for different stimulation frequencies is shown for normal
conditions using the GPB model (thick line), for basic HF
conditions (solid line), and for a 15% increase (long dashed line)
and a 15% reduction (short dashed line) of all the ionic parameters
simultaneously with respect to their value in the basic HF model.
(TIF)
Figure S4 Sensitivity of rate-dependent changes in
systolic [Ca
2+]i to variations in individual ionic param-
eters in HF. Systolic [Ca
2+]i after 10 minutes of stimulation at
increasing rates is shown for normal conditions using the GPB
model (thick line), for basic HF conditions (solid line), and for a
15% increase (long dashed line) and a 15% reduction (short
dashed line) of one ionic parameter with respect to its value in the
basic HF model.
(TIF)
Figure S5 Sensitivity of rate-dependent changes in
systolic [Ca
2+]i to variations in all ionic parameters in
HF. Systolic [Ca
2+]i after 10 minutes of stimulation at increasing
rates is shown for normal conditions using the GPB model (thick
line), for basic HF conditions (solid line), and for a 15% increase
(long dashed line) and a 15% reduction (short dashed line) of all
the ionic parameters simultaneously with respect to their value in
the basic HF model.
(TIF)
Figure S6 Sensitivity of rate-dependent changes in dia-
stolic [Ca
2+]i to variations in individual ionic parameters
in HF. Diastolic [Ca
2+]i after 10 minutes of stimulation at
increasing rates is shown for normal conditions using the GPB
model (thick line), for basic HF conditions (solid line), and for a
15% increase (long dashed line) and a 15% reduction (short
dashed line) of one ionic parameter with respect to its value in the
basic HF model.
(TIF)
Figure S7 Sensitivity of rate-dependent changes in
diastolic [Ca
2+]i to variations in all ionic parameters in
HF. Diastolic [Ca
2+]i after 10 minutes of stimulation at increasing
rates is shown for normal conditions using the GPB model (thick
line), for basic HF conditions (solid line), and for a 15% increase
(long dashed line) and a 15% reduction (short dashed line) of all
the ionic parameters simultaneously with respect to their value in
the basic HF model.
(TIF)
Figure S8 Sensitivity of rate-dependent changes in
[Na
+]i to variations in individual ionic parameters in
HF. [Na
+]i after 10 minutes of stimulation at increasing rates is
shown for normal conditions using the GPB model (thick line), for
basic HF conditions (solid line), and for a 15% increase (long
dashed line) and a 15% reduction (short dashed line) of one ionic
parameter with respect to its value in the basic HF model.
(TIF)
Figure S9 Sensitivity of rate-dependent changes in
[Na
+]i to variations in all ionic parameters in HF.
[Na
+]i after 10 minutes of stimulation at increasing rates is shown
for normal conditions using the GPB model (thick line), for basic
HF conditions (solid line), and for a 15% increase (long dashed
line) and a 15% reduction (short dashed line) of all the ionic
parameters simultaneously with respect to their value in the basic
HF model.
(TIF)
Figure S10 Sensitivity of EAD generation to variations
in individual ionic parameters in HF. Steady-state APs at 1-
Hz pacing rate with 50% inhibition of IKr, 30% increase of ICaL.
The simulated results using the basic HF model are shown with a
thick line, the solid and dashed lines show the results obtained for a
15% increase and a 15% reduction, respectively, of one ionic
parameter with respect to its value in the basic HF model.
(TIF)
Figure S11 Sensitivity of EAD generation to variations
in all ionic parameters in HF. Steady-state APs at 1-Hz
pacing rate with 50% inhibition of IKr, 30% increase of ICaL. The
simulated results using the basic HF model are shown with a thick
line, the solid and dashed lines show the results obtained for a 15%
increase and a 15% reduction, respectively, of all the ionic
parameters simultaneously with respect to their value in the basic
HF model.
(TIF)
Figure S12 Mechanisms for early afterdepolarizations
with a 50% continuous block of Irel. Simulated APs and ionic
currents at 1-Hz pacing rate under HF conditions, 50% inhibition
of IKr, 30% increase of ICaL. Panel A shows EADs (dark line) with
the basic HF value of Irel and APs with no EADs when Irel was
50% blocked (light line). The temporal evolutions of INaL (panel
B), [Ca
2+]SR (panel C), Irel (panel D), NCX activity (panel E), and
activation gate of ICaL (panel F) are also depicted with the basic
HF value of Irel (dark line) and when Irel was 50% blocked (light
line).
(TIF)
Simulation Study of Heart Failure
PLoS ONE | www.plosone.org 11 March 2012 | Volume 7 | Issue 3 | e32659Figure S13 Mechanisms for early afterdepolarizations
with a 50% transitory block of Irel. Simulated APs and ionic
currents at 1-Hz pacing rate under HF conditions, 50%
inhibition of IKr, 30% increase of ICaL. Panel A shows EADs
(dark line) with the basic HF value of Irel and APs with no EADs
when Irel was 50% blocked (light line) during the 5 stimulations
indicated by a horizontal line. The temporal evolutions of INaL
(panel B), [Ca
2+]SR (panel C), Irel (panel D), NCX activity (panel
E), and activation gate of ICaL (panel F) are also depicted with the
basic HF value of Irel (dark line) and when Irel was 50% blocked
(light line) during the 5 stimulations indicated by a horizontal
line.
(TIF)
Figure S14 Mechanisms for early afterdepolarizations
with a 50% continuous block of INCX. Simulated APs and
ionic currents at 1-Hz pacing rate under HF conditions, 50%
inhibition of IKr, 30% increase of ICaL. Panel A shows EADs (dark
line) with the basic HF value of INCX and APs with no EADs when
INCX was 50% blocked (light line). The temporal evolutions of INaL
(panel B), [Ca
2+]SR (panel C), Irel (panel D), NCX activity (panel
E), and activation gate of ICaL (panel F) are also depicted with the
basic HF value of INCX (dark line) and when INCX was 50%
blocked (light line).
(TIF)
Figure S15 Mechanisms for early afterdepolarizations
with a 50% transitory block of INCX. Simulated APs and
ionic currents at 1-Hz pacing rate under HF conditions, 50%
inhibition of IKr, 30% increase of ICaL. Panel A shows EADs (dark
line) with the basic HF value of INCX and APs with no EADs when
INCX was 50% blocked (light line during the 5 stimulations
indicated by a horizontal line. The temporal evolutions of INaL
(panel B), [Ca
2+]SR (panel C), Irel (panel D), NCX activity (panel
E), and activation gate of ICaL (panel F) are also depicted with the
basic HF value of INCX (dark line) and when INCX was 50%
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